Locally advanced breast cancer is the number of dissected nodes after neoadjuvant chemotherapy important?
The results of the study indicate that the number of nodes removed during AD does not affect survival (OS and EFS) in patients with neoadjuvant (ypN0/ypN+) BC. Axillary staging remains a key factor in the management of BC; therefore, an individualised approach considering the response to triple negative breast cancer and tumour burden in therapeutic decision making is recommended.
Authors
- Josepmilly del Valle Peña Colmenares
- Osama Bahsas Zaky
- Wladimir José Villegas Rodríguez
- Carlos Martínez (ORCID: https://orcid.org/0009-0006-1714-0984)
- Douglas José Angulo Herrera
Institutions
- Twitter (United States) (US)
- Hospital Clínico Universitario de Caracas (VE)
- Universidad Central de Venezuela (VE)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2026-01-30
- DOI
- https://doi.org/10.3332/ecancer.2026.2070
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00